跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Myracof
Approved
STANDARD
Myracof
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e6eb5e1373bce66e
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
e6eb5e1373bce66e
Drug Approval Philippines Name
Myracof
Product Name
Myracof
Registration Number
DR-XY15811
Brand Name
Myracof
Generic Name
Ambroxol hydrochloride
Dosage Form
Syrup
Dosage Strength
30mg per 5mL
Manufacturer
Amherst Laboratories, Inc.
Trader
Medichem Pharmaceuticals, Inc.
Issuance Date
29 April 2022
Expiry Date
04 January 2027
Pharmacologic Category
Mucolytic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e6eb5e1373bce66e
Type
Standard
Back to Philippines FDA Approvals
Myracof - Philippines FDA Drug Approval Details